Bottom line
TNA vs LABU: the short answer
TNA (Direxion Daily Small Cap Bull 3X ETF) and LABU (Direxion Daily S&P Biotech Bull 3X ETF) are quite different portfolios: only about 23% of their top holdings (by weight) are shared.
But LABU is far broader, holding 163 positions to 12 for TNA, so beyond the top names it adds exposure TNA doesn't have.
LABU is cheaper at 0.96% vs 1.05% — a difference of $9.00 a year per $10,000 invested.
Over five years, TNA returned −6.5% a year vs −39.6% for LABU.
Updated Nov 19, 2026
TNA vs LABU side by side
| TNA | LABU | |
|---|---|---|
| Type | ETF | ETF |
| Fund family | Direxion | Direxion |
| Category | Leveraged & Inverse | Leveraged & Inverse |
| Expense ratio | 1.05% | 0.96% |
| Annual cost per $10k | $105 | $96 |
| 10-yr cost on $10k (prospectus) | $1,304 | $1,178 |
| Max front load | None | None |
| 12b-1 fee | 0% | 0% |
| 1-yr return | +9.8% | +78.7% |
| 5-yr return (annualized) | −6.5% | −39.6% |
| 10-yr return (annualized) | +4.1% | −20.8% |
| Best quarter | +116.8% | +161.5% |
| Worst quarter | −76.9% | −67.4% |
| Net assets (fund) | $1.3B | $494.4M |
| Number of holdings | 12 | 163 |
| Portfolio turnover | 188% | 107% |
| Returns as of | Dec 31, 2025 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | TNA | LABU | Difference |
|---|---|---|---|
| 2025 | +9.8% | +78.7% | −68.9% |
| 2024 | +7.3% | −25.9% | +33.2% |
| 2023 | +26.0% | −13.4% | +39.4% |
| 2022 | −62.4% | −80.3% | +17.9% |
| 2021 | +28.1% | −64.3% | +92.4% |
| 2020 | −8.2% | +74.7% | −82.9% |
| 2019 | +71.8% | +74.6% | −2.8% |
| 2018 | −39.7% | −57.3% | +17.5% |
| 2017 | +39.6% | +148.7% | −109.1% |
| 2016 | +58.0% | −63.0% | +121.0% |
Source: Fund prospectus bar charts
Holdings overlap
10 of TNA's top 12 holdings also appear in LABU's top 25.
| Holding | TNA | LABU |
|---|---|---|
| Dreyfus | 16.60% | 15.86% |
| N/a | 6.49% | 3.87% |
| Goldman Sachs Liq Es Fd A | 6.27% | 5.35% |
| Goldman Financial | 4.72% | 14.83% |
| N/a | 4.64% | 3.87% |
| N/a | 4.63% | 3.87% |
| N/a | 4.18% | 3.87% |
| N/a | 1.86% | 3.87% |
| N/a | 1.39% | 3.87% |
| N/a | 0.89% | 3.87% |
Source: SEC Form N-PORT
TNA top 10
- Ishares MSCI Eafe Small-cap — 69.70%
- Dreyfus — 16.60%
- N/a — 6.49%
- Goldman Sachs Liq Es Fd A — 6.27%
- Goldman Financial — 4.72%
- N/a — 4.64%
- N/a — 4.63%
- N/a — 4.18%
- N/a — 1.86%
- Dreyfus — 1.59%
LABU top 10
- Dreyfus — 15.86%
- Goldman Financial — 14.83%
- N/a — 9.63%
- N/a — 7.30%
- Goldman Sachs Liq Es Fd A — 5.35%
- N/a — 4.85%
- N/a — 3.87%
- Apogee Therapeutics Inc — 1.11%
- Oruka Therapeutics Inc — 1.03%
- Dianthus Therapeutics Inc — 0.96%
FAQ
What is the difference between TNA and LABU?
Which is cheaper, TNA or LABU?
Should I own both TNA and LABU?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.